LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $379,474 | -81.3% | 6,333 | -77.0% | 0.00% | -75.0% |
Q1 2023 | $2,029,005 | -67.3% | 27,583 | -70.3% | 0.00% | -71.4% |
Q4 2022 | $6,203,249 | +80.6% | 92,863 | +132.8% | 0.01% | +75.0% |
Q3 2022 | $3,434,000 | -3.5% | 39,883 | 0.0% | 0.01% | +14.3% |
Q2 2022 | $3,559,000 | +191.0% | 39,883 | +354.5% | 0.01% | +40.0% |
Q3 2021 | $1,223,000 | +91.7% | 8,776 | +36.8% | 0.01% | +66.7% |
Q4 2020 | $638,000 | +72.9% | 6,415 | +26.3% | 0.00% | -25.0% |
Q1 2020 | $369,000 | -89.3% | 5,078 | -83.2% | 0.00% | -85.7% |
Q2 2019 | $3,448,000 | -75.6% | 30,205 | -73.1% | 0.03% | -58.2% |
Q1 2019 | $14,122,000 | -32.7% | 112,322 | -27.3% | 0.07% | -68.7% |
Q4 2018 | $20,971,000 | +3383.6% | 154,535 | +6956.4% | 0.21% | +7033.3% |
Q3 2018 | $602,000 | -48.7% | 2,190 | -61.3% | 0.00% | -83.3% |
Q2 2018 | $1,173,000 | -76.8% | 5,662 | -94.0% | 0.02% | -73.1% |
Q4 2014 | $5,062,000 | -44.5% | 95,128 | -51.0% | 0.07% | -49.2% |
Q3 2014 | $9,125,000 | +4224.6% | 194,181 | +5631.4% | 0.13% | +4300.0% |
Q2 2014 | $211,000 | -93.4% | 3,388 | -92.8% | 0.00% | -94.8% |
Q1 2014 | $3,179,000 | – | 47,271 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $7,682 | 2.90% |
VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |